Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro.
The basal release of vasopressin from the isolated neural lobe of the rat decreased in the presence of exogenous cAMP, 8Br-cAMP, diB-cAMP, theophylline, SQ 20,009 and RO20-1724. The concentration-related decrease in vasopressin release, in the presence of phosphodiesterase inhibitors, was accompanied by a progressive increase in cAMP concentration in the neural lobe. The findings suggest a local modulation of vasopressin release from the neural lobes.
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004974:Etazolate / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D014667:Vasopressins / Q000378:metabolism*; D014970:Xanthines / Q000494:pharmacology
D014970:Xanthines; D014667:Vasopressins; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D002110:Caffeine; D003994:Bucladesine; D010208:Papaverine; D000242:Cyclic AMP; D004974:Etazolate